Patents by Inventor Annabelle Lemenuel

Annabelle Lemenuel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11911394
    Abstract: The present invention relates to a method for preventing transmission of influenza, wherein said method comprises administering an effective amount of a compound to a patient having an influenza virus infection, herein referred to as “index patient”, wherein the compound has one of the formulae (I) and (II), or its pharmaceutically acceptable salt. The compound to be used in the present invention reduces infectivity of the influenza virus of the index patient, and therefore, reduces the risk of the index patient to trigger an influenza epidemic or an influenza pandemic as compared to a control patient.
    Type: Grant
    Filed: December 23, 2021
    Date of Patent: February 27, 2024
    Assignees: Shionogi & Co., Ltd.
    Inventors: Takeshi Noshi, Takahiro Noda, Ryu Yoshida, Takao Shishido, Kaoru Baba, Aeron C. Hurt, Leo Yi Yang Lee, Steffen Wildum, Klaus Kuhlbusch, Barry Clinch, Jan Michal Nebesky, Annabelle Lemenuel, Wendy S. Barclay, Jean-Eric Charoin, Yoshinori Ando
  • Publication number: 20220370447
    Abstract: The present invention relates to method of treating HBV infection in a human patient, wherein the method comprises administration of a therapeutically effective amount of Compound (I), or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 18, 2020
    Publication date: November 24, 2022
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Qingyan BO, Valérie COSSON, Sheng FENG, Lu GAO, Yuyan JIN, Annabelle LEMENUEL, Miriam TRIYATNI, Xue ZHOU, Mingfen ZHU
  • Publication number: 20220331331
    Abstract: The present invention relates to a method for preventing transmission of influenza, wherein said method comprises administering an effective amount of a compound to a patient having an influenza virus infection, herein referred to as “index patient”, wherein the compound has one of the formulae (I) and (II), or its pharmaceutically acceptable salt. The compound to be used in the present invention reduces infectivity of the influenza virus of the index patient, and therefore, reduces the risk of the index patient to trigger an influenza epidemic or an influenza pandemic as compared to a control patient.
    Type: Application
    Filed: December 23, 2021
    Publication date: October 20, 2022
    Inventors: Takeshi NOSHI, Takahiro NODA, Ryu YOSHIDA, Takao SHISHIDO, Kaoru BABA, Aeron C. HURT, Leo Yi Yang LEE, Steffen WILDUM, Klaus KUHLBUSCH, Barry CLINCH, Jan Michal NEBESKY, Annabelle LEMENUEL, Wendy S. BARCLAY, Jean-Eric CHAROIN, Yoshinori ANDO
  • Patent number: 11389457
    Abstract: The present invention relates to a method for preventing transmission of influenza, wherein said method comprises administering an effective amount of a compound to a patient having an influenza virus infection, herein referred to as “index patient”, wherein the compound has one of the formulae (I) and (II), or its pharmaceutically acceptable salt. The compound to be used in the present invention reduces infectivity of the influenza virus of the index patient, and therefore, reduces the risk of the index patient to trigger an influenza epidemic or an influenza pandemic as compared to a control patient.
    Type: Grant
    Filed: March 26, 2020
    Date of Patent: July 19, 2022
    Assignees: Hoffmann-La Roche Inc., Shionogi & Co., Ltd.
    Inventors: Takeshi Noshi, Takahiro Noda, Ryu Yoshida, Takao Shishido, Kaoru Baba, Aeron C. Hurt, Leo Yi Yang Lee, Steffen Wildum, Klaus Kuhlbusch, Barry Clinch, Jan Michal Nebesky, Annabelle Lemenuel, Wendy S. Barclay, Jean-Eric Charoin, Yoshinori Ando
  • Publication number: 20200330473
    Abstract: The present invention relates to a method for preventing transmission of influenza, wherein said method comprises administering an effective amount of a compound to a patient having an influenza virus infection, herein referred to as “index patient”, wherein the compound has one of the formulae (I) and (II), or its pharmaceutically acceptable salt. The compound to be used in the present invention reduces infectivity of the influenza virus of the index patient, and therefore, reduces the risk of the index patient to trigger an influenza epidemic or an influenza pandemic as compared to a control patient.
    Type: Application
    Filed: March 26, 2020
    Publication date: October 22, 2020
    Inventors: Takeshi NOSHI, Takahiro NODA, Ryu YOSHIDA, Takao SHISHIDO, Kaoru BABA, Aeron C. HURT, Leo Yi Yang LEE, Steffen WILDUM, Klaus KUHLBUSCH, Barry CLINCH, Michael J. NEBESKY, Annabelle LEMENUEL-DIOT, Wendy S. BARCLAY, Jean-Eric CHAROIN, Yoshinori ANDO